Navigation Links
New Test for Diagnosing Attention-Deficit/Hyperactivity Disorder (ADHD)
Date:8/27/2013

Sturgeon Bay, WI (PRWEB) August 27, 2013

Attention-Deficit/Hyperactivity Disorder (ADHD) is a widespread neurobehavioral disorder seen in children and teens. It is characterized by inattention, impulsivity and behavioral difficulties, and/or over-activity not normal for one’s age group. Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP states that the Centers for Disease Control and Prevention estimates 6.4 million American children have been diagnosed with ADHD, of which nearly 3 million are taking Ritalin, Adderall or other mind-altering drugs. This is a 41% increase in the last 10 years, which has led to many questions about the validity of the diagnosis.

Last month, the U.S. Food and Drug Administration (USDA) approved the first brain wave test to diagnose ADHD. This non-invasive 20-minute test has been authorized for use as part of a complete psychological exam of 6 to 17 year old patients to confirm or rule out a diagnosis of ADHD.

Nicknamed NEBA (Neuropsychiatric Interpretive Electroencephalograph Assessment Aid), it is the culmination of 7 years of research by a small start-up company of 10 people. Produced by NEBA Health of Augusta, Georgia, the device is already used in assessing sleep disorders, measuring unconsciousness, diagnosing the side effects of head injuries, and monitoring the brain during surgery. To diagnose ADHD, the NEBA calculates the ratio between theta (slow) and beta (fast) brain waves. The researchers found that beta waves are higher than normal in those with ADHD. Their research continues as plans are underway to extend its capabilities to diagnosing depression and dementia.

The research for the NEBA was done with 275 youths between the ages of 6 and 17 years who displayed, but had not been treated for, attention or behavioral problems. A group of ADHD experts reviewed test results derived from using the criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), behavioral questionnaires and testing, and physical examinations to arrive at a consensus diagnosis of whether ADHD was present or not. There was a 61% agreement among the doctors when using the standard tests for ADHD, and this increased to 88% when the NEBA device was included.

NEBA testing does have its skeptics though. Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Steven & Alexandra Cohen Children's Medical Center in New Hyde Park, New York stated, "For clinicians and researchers interested in ADHD, an objective diagnostic test that is accurate, sensitive and specific has been one of the 'holy grails' which has long been sought. It is doubtful that this EEG test newly approved by the FDA will be as accurate and reliable as clinicians and families would ideally want. Although this new EEG test may prove helpful to clinicians, neither parents nor professionals will be able to rely upon it as a standalone 'litmus test' for whether a child has ADHD." Adesman also points out that the NEBA device may fare no better than the other “objective” diagnostic tests for ADHD that the FDA has approved but have not come into common acceptance for diagnosing the disorder.

Dr. Daniel Amen has been researching the use of single photon emission computed tomography (SPECT) imaging in making neuropsychiatric diagnoses since 1991. SPECT scans use radioisotopes to track the function in the brain by looking at blood flow and activity patterns. He has discovered that there are at least six different forms of ADHD, each responsive to a different treatment protocol. While further research needs to be done, the results have been promising in getting to the root causes for many ADHD patients when their previous treatments have failed.

Using the latest research findings, Moellendorf Chiropractic Office, Ltd. uses a comprehensive package of Chiropractic care, decompression traction therapy, active therapeutic movement training, cold laser therapy, and nutrition for the natural treatment of neurological conditions, neck and back pain, and other health conditions such as ADHD without drugs or surgery. Additional information about Chiropractic, Naturopathy, and other forms of natural health care has been provided by Moellendorf Chiropractic Office, Ltd. at http://www.all-about-wellness.com.

About: Dr. J G Moellendorf, DC, ND, LCP
Dr. J G Moellendorf, DC, ND, LCP attended the University of Wisconsin—Superior where he majored in Physics and Mathematics, with a minor in art photography. While attending the University of Minnesota—Minneapolis, he assisted in research on ribosomal proteins. Completing his Chiropractic studies at Palmer College of Chiropractic in Davenport, Iowa, he graduated Cum Laude (with high honors) in 1983. He started Moellendorf Chiropractic Office, Ltd. in Sturgeon Bay, Wisconsin in 1983. In 1996, Dr. Moellendorf was awarded his Doctorate in Naturopathy from Trinity School of Natural Health. In 2001, he received Chiropractic’s most prestigious award, the honorary Legion of Chiropractic Philosophers degree, for his thesis “The Workings of Innate Intelligence in Obsessive/Compulsive and Addictive Behaviors.” This paper was chosen for publishing in the book Philosophic Contemplations vol. 2 in 2002. In June of 2012, Dr. Moellendorf authored his first book titled Healthcare’s Best Kept Secret which can be ordered on Amazon.

Dr. Moellendorf can be contacted by phone (920) 493-2126, fax (920) 743-1145, email jgmoellendorf(at)itol(dot)com, his website at http://www.all-about-wellness.com, or send a carrier pigeon to 44.84722N and 87.36416W.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11055150.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
2. Market for Biologic Imaging Reagents and Medical Imaging & Diagnosing Analyzed in New Research Reports at ReportsnReports.com
3. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
4. Pediatric Feeding Institute Revolutionizes the Treatment of Childrens Feeding Disorders with Mealtime Miseries Live Seminars
5. arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders
6. In Focus with Martin Sheen Showcasing How Medication is Helping Win the Fight Against Mood Disorders
7. Combination of Key Nutrients Reduces Stress and Emotional Problems in Those with Attention Deficit Hyperactivity Disorder (ADHD) Research Shows
8. Intrinsically disordered proteins: A conversation with Rohit Pappu
9. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
10. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
11. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
Breaking Biology Technology:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):